Acute Coronary Syndrome

Links:

Revascularization:
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes

NSTEMI:
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

DAPT:
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease


THREE CLINICAL ENTITIES:  Unstable Angina, NSTEMI, STEMI

Unstable Angina – chest pain + EKG changes but normal troponin and CK-MB

NSTEMI – (Type 1 due to plaque rupture) — EKG changes + troponin or CK-MB

STEMI – complete occlusion of coronary artery; chest pain + ST elevations + troponin

Unstable Angina

  • Characteristics of chest pain
    • increasing in duration, intensity, frequency OR
    • resistant to nitroglycerin OR
    • new onset severe chest pain with normal activity OR
    • resting chest pain OR
    • chest pain within 2 weeks after MI
  • EKG changes
    • ST depression > 0.5 mm
    • T-wave inversions > 3mm
    • Transient ST elevations last less than 20 minutes

UA/NSTEMI

  • Use TIMI score to risk stratify patients presenting with CP suspicious for unstable angina v. NSTEMI
  • TIMI score estimates risk of new or recurrent MI, severe recurrent ischemia requiring re-vascularization, and all-cause mortality in patients presenting with unstable angina or NSTEMI
  • “AMERICA” mnemonic – 1 point for each
    • Age > 65
    • Markers – elevated troponin
    • EKG w/ ST depressions of 0.5 mm in contiguous leads
    • Risk factors of 3 or more
      • HTN > 140/90 or on anti-hypertensives
      • Cigarette smoker
      • HDL < 40
      • Diabetic
      • Family hx of pre-mature CAD
        • male 1st degree < 55 y/o, female 1st degree < 65 yo
      • Ischemia –2 or more angina events in 24 hours
      • CAD – known diagnosis w/ CA stenosis > 50%
      • Aspirin use in the past 7 days

STEMI

  • Door to PCI Time 90min
  • If no PCI available, fibrinolysis within 30 minutes of presentation with immediate transfer to facility capable of PCI
  • ALL PATIENTS WITH STEMI –need ASA, antiplatelet (P2Y12 or glycoprotein IIb/IIIa inhibitor), BB (oral within 24 hours, unless contraindicated), ACE-I, statin and referral to cardiac rehabilitation

Scroll to Top